These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4876929)

  • 1. [Aspects of hemostasis in experimental pulmonary homotransplant].
    Morino F; Olivero S; Traldi A; Bezzi P; Vezzosi E; Ibra F; Romagna I
    Minerva Med; 1968 Jul; 59(59):3267-76. PubMed ID: 4876929
    [No Abstract]   [Full Text] [Related]  

  • 2. [On coagulation inhibiting effect of proteinase inhibitors from animal organs].
    Gülzow M; Schulz K
    Z Gesamte Inn Med; 1967 Nov; 22(21):641-7. PubMed ID: 5302275
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD
    Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the combined effect of PAMBA and contrykal].
    Richter M; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):90-2. PubMed ID: 4189379
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products.
    Trzebicki J; Flakiewicz E; Kosieradzki M; Blaszczyk B; Kołacz M; Jureczko L; Pacholczyk M; Chmura A; Lagiewska B; Lisik W; Wasiak D; Kosson D; Kwiatkowski A; Lazowski T
    Ann Transplant; 2010; 15(3):19-24. PubMed ID: 20877262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences between neonates and adults in plasmin inhibitory and antifibrinolytic action of aprotinin.
    Zenker M; Ries M
    Thromb Res; 2002 Jul; 107(1-2):17-21. PubMed ID: 12413584
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of aprotinin and tranexamic acid on fibrinolysis and thrombin generation during cardiopulmonary bypass].
    Risch A; Dorscheid E; Stein G; Seyfert UT; Grundmann U
    Anaesthesist; 2000 Apr; 49(4):279-85. PubMed ID: 10840537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
    Zetterqvist E
    Acta Physiol Scand Suppl; 1969; 325():1-41. PubMed ID: 4900570
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiplasmins].
    Enache F; Cecil P
    Med Interna (Bucur); 1970 Jun; 22(6):667-76. PubMed ID: 4917257
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents.
    Flight S; Johnson L; Trabi M; Gaffney P; Lavin M; de Jersey J; Masci P
    Pathophysiol Haemost Thromb; 2005; 34(4-5):188-93. PubMed ID: 16707925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the fibrinogen splitting products in the blood plasma in hyperfibrinolysis].
    Veremienko KN; Varetskaia TV; Kizim AI; Gerasimenko NG
    Ukr Biokhim Zh; 1976; 48(3):337-42. PubMed ID: 134480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery.
    Ambrus JL; Schimert G; Lajos TZ; Ambrus CM; Mink IB; Lassman HB; Moore RH; Melzer J
    J Med; 1971; 2(2):65-81. PubMed ID: 4329735
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of hemostasis and fibrinolysis in the metastatic spread of cancer.
    Markus G
    Semin Thromb Hemost; 1984 Jan; 10(1):61-70. PubMed ID: 6538342
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysis.
    Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1995 May; 73(5):845-9. PubMed ID: 7482414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of antifibrinolytic agents results in a reduction in transfused blood products during liver transplantation.
    Ramsay MA
    Liver Transpl Surg; 1997 Nov; 3(6):665-8. PubMed ID: 9404974
    [No Abstract]   [Full Text] [Related]  

  • 19. [p-Aminomethylbenzoic acid ethylester--an effective oral antifibrinolytic agent].
    Klöcking HP
    Z Arztl Fortbild (Jena); 1967 Sep; 61(17):880-2. PubMed ID: 5589350
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative studies on inhibitors of fibrinolysis in vitro and in vivo.
    Deutsch E; Fischer M
    Acta Haematol; 1968; 39(1):1-12. PubMed ID: 4968865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.